Mel Blumenthal
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Heart Failure Treatment and Management 5
- Cardiac pacing and defibrillation studies 2
- Cardiovascular Function and Risk Factors 1
-
- Cardiovascular and exercise physiology 2
- Co-authors
- Salim Yusuf (2 shared papers)Thomas Wittlinger (1 shared paper)Patrick Commerford (1 shared paper)Shamir R. Mehta (1 shared paper)Andrzej Budaj (1 shared paper)Keith A.A. Fox (1 shared paper)Bernard John Gersh (1 shared paper)Feng Zhao (1 shared paper)
- Journals
- CHEST Journal (1 paper)European Heart Journal (1 paper)The American Journal of Cardiology (1 paper)Cardiovascular Drug Reviews (1 paper)American Journal of Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mel Blumenthal
9 papers receiving 462 citations
Peers
Comparison fields: 5 of 63
- Cardiology and Cardiovascular Medicine 307
- Internal Medicine 42
- Statistics, Probability and Uncertainty 21
- Radiology, Nuclear Medicine and Imaging 52
- Surgery 86
Countries citing papers authored by Mel Blumenthal
This map shows the geographic impact of Mel Blumenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Blumenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Blumenthal more than expected).
Fields of papers citing papers by Mel Blumenthal
This network shows the impact of papers produced by Mel Blumenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Blumenthal. The network helps show where Mel Blumenthal may publish in the future.
Co-authors
The 25 scholars most cited alongside Mel Blumenthal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 235 | |
| 2 | 2008 | 143 | |
| 3 | 1995 | 69 | |
| 4 | 1995 | 35 | |
| 5 | 1988 | 23 | |
| 6 | 1999 | 6 | |
| 7 | 1998 | 5 | |
| 8 | Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure. | 2002 | 3 |
| 9 | 1999 | 1 |
About Mel Blumenthal
Mel Blumenthal is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Family Practice, Geriatrics and Gerontology and Anesthesiology and Pain Medicine, having authored 9 papers that have together received 520 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (5 papers), Cardiovascular and exercise physiology (2 papers), Cardiac pacing and defibrillation studies (2 papers), Cardiovascular Function and Risk Factors (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Meta-analysis and systematic reviews (1 paper), Medication Adherence and Compliance (1 paper) and Pain Management and Treatment (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (307 citations), Internal Medicine (42 citations), Statistics, Probability and Uncertainty (21 citations), Radiology, Nuclear Medicine and Imaging (52 citations) and Surgery (86 citations). Mel Blumenthal has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Salim Yusuf, Thomas Wittlinger, Patrick Commerford, Shamir R. Mehta, Andrzej Budaj, Keith A.A. Fox, Bernard John Gersh, Feng Zhao, Kate Gelperin and John P. Ilgenfritz. Their work appears in journals such as CHEST Journal, European Heart Journal, The American Journal of Cardiology, Cardiovascular Drug Reviews and American Journal of Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.